About factors affacting posology
Non-aggressive/irreversible antagonism: If an antagonist binds on the receptor and precludes agonist activation of that receptor by its occupancy, then no amount of agonist existing while in the receptor compartment can overcome this antagonism is termed non-competitive.Such as, as a substrate of each CYP3A and P-gp, tacrolimus concentrations will